SCHEMBL7985279

SCHEMBL7985279

O=c1nc(-c2ccncc2)[nH]c2ncn(Cc3ccc(F)cc3)c12

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNOT7 Q9UIV1 3/20 0.49
ALOX5 P09917 8/20 0.42
KDM4E B2RXH2 2/20 0.42
GSK3B P49841 2/20 0.40
PARN O95453 1/20 0.40
NFATC1 O95644 1/20 0.40
DYRK1A Q13627 1/20 0.40
MAPK14 Q16539 4/20 0.40
MAPK13 O15264 3/20 0.40
GCGR P47871 3/20 0.40
MAPK12 P53778 3/20 0.40
MAPK11 Q15759 3/20 0.40
PRKD3 O94806 1/20 0.40
MAP4K4 O95819 1/20 0.40
FRK P42685 1/20 0.40
MAPK9 P45984 1/20 0.40
CSNK1A1 P48729 1/20 0.40
CSNK1D P48730 1/20 0.40
PTK6 Q13882 1/20 0.40
PRKD2 Q9BZL6 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7984283 0.93 CNOT7 (0.43) CNOT7KDM4EPARNHTTSMN1; SMN2
SCHEMBL7986522 0.90 CNOT7 (0.48) CNOT7KDM4EPARNHTTSMN1; SMN2
SCHEMBL7985827 0.89 CNOT7 (0.49) CNOT7KDM4EPARNMAPK14MAPK13
SCHEMBL7974444 0.88 CNOT7 (0.52) CNOT7KDM4EGSK3BPARNSMN1; SMN2
SCHEMBL7985168 0.88 KMT2A (0.46) CNOT7KDM4EPARNMAPK14MAPK13
SCHEMBL7974508 0.87 CNOT7 (0.51) CNOT7KDM4EPARNSMN1; SMN2LMNA
SCHEMBL7985266 0.87 CNOT7 (0.43) CNOT7KDM4EPARNMAPK14MAPK13
SCHEMBL7989422 0.87 CNOT7 (0.47) CNOT7PARNDYRK1AHTTSMN1; SMN2
SCHEMBL7984934 0.86 CNOT7 (0.47) CNOT7KDM4EPARNGCGRLMNA
SCHEMBL7987364 0.85 TNKS (0.46) CNOT7KDM4EPARNMAPK14HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed